Gene expression profiling of T-ALL cases has led to the identification of subgroups of T-ALL, each characterized by aberrant expression of one particular transcription factor such as TAL1, TLX1, and LMO1/23,4. The gene discussed is LMO1; the disease is acute lymphoblastic leukemia.